Endo International plc

306 articles about Endo International plc

• Endo International Announces Departure Of Chief Financial Officer

  10/21/2016

• Endo International To Announce Third Quarter 2016 Financial Results On November 8, 2016

  10/18/2016

• Endo International CEO Resigns, New Leader Named

  9/23/2016

• Endo International's President And CEO Adopts 10b5-1 Trading Plan

  8/19/2016

• Endo International Withdraws Its Supplemental NDA for Pain Drug OPANA

  8/12/2016

• Endo International Reports Second Quarter 2016 Financial Results

  8/9/2016

• Endo International Announces Appointment Of Joseph J. Ciaffoni As President, U.S. Branded Pharmaceuticals

  8/9/2016

• 3 Battered Biopharma Stocks Battling to Recover

  7/22/2016

• Endo International To Announce Second Quarter 2016 Financial Results On August 8, 2016

  7/18/2016

• Endo International Announces Issuance of Vasostrict Patent

  6/28/2016

• Endo International Announces Local Qualitest Scholarship Program Award Recipients

  6/10/2016

• Endo International Release: New Data Demonstrate Safety Of Long-Term, Around-The-Clock Treatment With BELBUCA (Buprenorphine) Buccal Film For Chronic Pain

  6/3/2016

• Endo International Employees Participate In 3rd Annual "Endo Gives" Day Of Volunteering, Giving Back To Local Communities Around The World

  5/25/2016

• Endo International Announces Change To Senior Management Team

  5/6/2016

• Endo International Announces Appointment Of Douglas S. Ingram And Todd B. Sisitsky To Its Board Of Directors

  5/6/2016

• 3 Bargain Biotechs to Buy

  5/4/2016

• Endo International Announces Appearances At Upcoming Conferences

  5/3/2016

• Endo International Announces U.S. District Court Ruling Upholding OPANA ER Intellectual Property

  5/2/2016

• Endo International To Announce First Quarter 2016 Financial Results On May 5, 2016

  4/22/2016

• Endo International Provides Statement Regarding Expected FDA Approval Of Generic Voltaren Gel Product

  3/21/2016